| Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq | Frank Vinluan | 05/22/20 | National |
| Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More | Frank Vinluan | 05/22/20 | National |
| Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More | Frank Vinluan | 05/08/20 | National |
| AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks | Sarah de Crescenzo | 05/06/20 | National |
| ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans | Frank Vinluan | 04/27/20 | New York |
| Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More | Sarah de Crescenzo | 04/17/20 | National |
| RDMD Lands $14M to Expand Reach of Rare Disease Research Platform | Sarah de Crescenzo | 04/16/20 | San Francisco |
| AstraZeneca Wins First FDA Drug Nod for NF1, a Rare Genetic Disorder | Frank Vinluan | 04/10/20 | National |
| Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs | Frank Vinluan | 04/09/20 | Boston |
| Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials | Frank Vinluan | 04/03/20 | New York |
| A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy | Frank Vinluan | 03/31/20 | Raleigh Durham |
| Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
| AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics | Frank Vinluan | 03/25/20 | Europe |
| Fears Of Recession Mount As Coronavirus Declared A Pandemic | Andrew McConaghie | 03/19/20 | National |
| The Benefits and Impact of Later In-Licensing Deals for Biopharma | Gareth Macdonald | 03/17/20 | National |
| Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street | Frank Vinluan | 03/09/20 | New York |
| Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More | Sarah de Crescenzo | 03/06/20 | National |
| Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More | Frank Vinluan | 02/28/20 | National |
| Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact | Frank Vinluan | 02/25/20 | Boston |
| Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More | Sarah de Crescenzo | 02/21/20 | National |
| Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs | Sarah de Crescenzo | 01/31/20 | San Diego |
| Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie | Frank Vinluan | 01/27/20 | National |
| After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune | Mike Ward | 01/23/20 | National |
| Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More | Frank Vinluan | 01/17/20 | National |
| Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More | Frank Vinluan | 01/03/20 | National |
| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets | Melissa Fassbender | 12/09/19 | Boston |
| AstraZeneca, Novoheart to Co-Develop New Heart Model | Melissa Fassbender | 11/27/19 | National |
| Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More | Frank Vinluan | 11/08/19 | National |
| AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund | Gareth Macdonald | 11/06/19 | National |
